Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion type Assertion NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_head.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion description "[This study was designed in accordance with the hypothesis that polymorphisms (-37 and -524) of the RRM1 promoter gene sequence, which regulate RRM1 expression, could influence the efficacy and prognosis of lung cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_provenance.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion evidence source_evidence_literature NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_provenance.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion SIO_000772 18483375 NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_provenance.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion wasDerivedFrom befree-20140225 NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_provenance.
- NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_assertion wasGeneratedBy ECO_0000203 NP504847.RAUxfcggBN8OdgxNVUEYmheaqG6xdDejn8rBDjEBVY3QQ130_provenance.